当前位置： SCI文献检索 > JOURNAL OF CLINICAL MICROBIOLOGY期刊下所有文献 > A Multiplexed Serologic Test for Diagnosis of Lyme Disease for Point-of-Care Use.

A Multiplexed Serologic Test for Diagnosis of Lyme Disease for Point-of-Care Use.

Abstract：

:Single multiplexed assays could replace the standard 2-tiered (STT) algorithm recommended for the laboratory diagnosis of Lyme disease if they perform with a specificity and a sensitivity superior or equal to those of the STT algorithm. We used human serum rigorously characterized to be sera from patients with acute- and convalescent-phase early Lyme disease, Lyme arthritis, and posttreatment Lyme disease syndrome, as well as the necessary controls (n = 241 samples), to select the best of 12 Borrelia burgdorferi proteins to improve our microfluidic assay (mChip-Ld). We then evaluated its serodiagnostic performance in comparison to that of a first-tier enzyme immunoassay and the STT algorithm. We observed that more antigens became positive as Lyme disease progressed from early to late stages. We selected three antigens (3Ag) to include in the mChip-Ld: VlsE and a proprietary synthetic 33-mer peptide (PepVF) to capture sensitivity in all disease stages and OspC for early Lyme disease. With the specificity set at 95%, the sensitivity of the mChip-Ld with 3Ag ranged from 80% (95% confidence interval [CI], 56% to 94%) and 85% (95% CI, 74% to 96%) for two panels of serum from patients with early Lyme disease and was 100% (95% CI, 83% to 100%) for serum from patients with Lyme arthritis; the STT algorithm detected early Lyme disease in the same two panels of serum from patients with early Lyme disease with a sensitivity of 48.5% and 75% and Lyme arthritis in serum from patients with Lyme arthritis with a sensitivity of 100%, and the specificity was 97.5% to 100%. The mChip-Ld platform outperformed the STT algorithm according to sensitivity. These results open the door for the development of a single, rapid, multiplexed diagnostic test for point-of-care use that can be designed to identify the Lyme disease stage.

journal_name

J Clin Microbiol

journal_title

Journal of clinical microbiology

authors

Arumugam S,Nayak S,Williams T,di Santa Maria FS,Guedes MS,Chaves RC,Linder V,Marques AR,Horn EJ,Wong SJ,Sia SK,Gomes-Solecki M

doi

10.1128/JCM.01142-19

subject

Has Abstract

pub_date

2019-11-22 00:00:00

issue

eissn

0095-1137

issn

1098-660X

pii

JCM.01142-19

journal_volume

pub_type

杂志文章

在线工具

A Multiplexed Serologic Test for Diagnosis of Lyme Disease for Point-of-Care Use.